Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JOUL | 21.00 | 0.32 | +1.57% |
| Corgi High Voltage Grid Equipment ETF (JOUL) | |||
| PAMC | 49.68 | 0.52 | +1.06% |
| Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC) | |||
| EAGL | 36.25 | 0.04 | +0.11% |
| Eagle Capital Select Equity ETF (EAGL) | |||
| HAPS | 36.13 | N/A | N/A |
| Harbor Human Capital Factor US Small Cap ETF (HAPS) | |||
| XSVM | 66.33 | -0.26 | -0.39% |
| Invesco S&P SmallCap Value with Momentum ETF (XSVM) | |||
A.I.dvisor indicates that over the last year, HAE has been loosely correlated with SRTS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then SRTS could also see price increases.
| Ticker / NAME | Correlation To HAE | 1D Price Change % | ||
|---|---|---|---|---|
| HAE | 100% | -0.93% | ||
| SRTS - HAE | 44% Loosely correlated | +4.00% | ||
| ECOR - HAE | 43% Loosely correlated | -1.87% | ||
| ATR - HAE | 41% Loosely correlated | -0.11% | ||
| PEN - HAE | 41% Loosely correlated | -0.24% | ||
| GH - HAE | 39% Loosely correlated | +2.50% | ||
More | ||||
| Ticker / NAME | Correlation To HAE | 1D Price Change % |
|---|---|---|
| HAE | 100% | -0.93% |
| Health Services category (240 stocks) | 1% Poorly correlated | -0.00% |
| Medical/Nursing Services category (139 stocks) | 0% Poorly correlated | -0.31% |
a manufacturer of blood processing systems
Industry MedicalNursingServices
The 10-day RSI Indicator for HAE moved out of overbought territory on October 16, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 instances where the indicator moved out of the overbought zone. In 31 of the 40 cases the stock moved lower in the days that followed. This puts the odds of a move down at 77%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 59 cases where HAE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
HAE broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on HAE as a result. In 45 of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for HAE just turned positive on October 08, 2026. Looking at past instances where HAE's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.
Following a +0.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in 235 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 162 of 209 cases where HAE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. HAE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.365) is normal, around the industry mean (2.923). P/E Ratio (56.303) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (1.676) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.668) is also within normal values, averaging (40.124).